AFEX Monthly Currency Report - June 2021

The fast-moving foreign exchange market trades more than $6 trillion daily. Understanding why it moves is half the battle. The AFEX Monthly Currency Outlook offers insight into market dynamics and currency pairs that may affect your business. However, we recognise every business is different and may have its own internal hedging policies. Speak with one of our specialists to discuss your business requirements and what works best for you.

To download the latest AFEX Currency Outlook, please fill in your details below. 


About AFEX

Established in 1979, AFEX is one of the world’s largest privately-owned non-bank providers of international payment and risk management solutions. AFEX serves more than 35,000 active commercial and private clients from offices across the EMEA, Americas and APAC, executing over one million transactions annually in more than 100 currencies.

Fill in your details to get immediate access to our monthly currency report
First Name
Last Name
Company
Email
Phone number

© 2021 Associated Foreign Exchange, Inc. All rights reserved. 


Associated Foreign Exchange Limited, which does business under the trade name of AFEX (registered in England and Wales, Company Number 4848033, Registered Office Address: 4th Floor, 40 Strand, London WC2N 5RW, United Kingdom), is authorised by the Financial Conduct Authority under the Payment Services Regulations 2017 (Register Reference: 502593) for the provision of payment services and is authorised to provide its products and services. AFEX is registered as an MSB with HM Revenue & Customs (Registered No: 12159000). AFEX Markets Plc (‘AFEX’) is authorised and regulated by the Financial Conduct Authority as an investment firm (firm reference number is 526034). Registered in England and Wales. Registered Office: 4th Floor, 40 Strand, London, WC2N 5RW (registered no. 07061516). For more information, visit www.afex.com

Foreign exchange options and other derivative products are not suitable for everyone and you should ensure you fully understand the risks involved before purchasing these products.

2021/167